Effects of ketamine, xylazine, and a combination of ketamine and xylazine in Pekin ducks

Effects of ketamine, xylazine, and a combination of ketamine and xylazine were studied in 12 male Pekin ducks (7 to 12 weeks old; mean [+/- SD] body weight, 3.1 +/- 0.3 kg). After venous and arterial catheterization and fixation of a temperature probe in the cloaca, each awake duck was confined, but not restrained, in an open box in a dimly lit room. Blood pressure and lead-II ECG were recorded. Three arterial blood samples were collected every 15 minutes over a 45-minute period (control period) and were analyzed for pHa, PaCO2 and PaO2. After the control period, each duck was assigned at random to 1 of 3 drug groups: (1) ketamine (KET; 20 mg/kg of body weight, IV), (2) xylazine (XYL; 1 mg/kg, IV), and (3) KET + XYL (KET 20 mg/kg and XYL, 1 mg/kg; IV). Measurements were made at 1, 5, 10, 15, 30, 45, 60, and 90 minutes after drug administration. All ducks survived the drug study. Cloacal temperature was significantly (P less than or equal to 0.05) increased above control cloacal temperature at 90 minutes after the administration of ketamine, and from 10 through 90 minutes after administration of ketamine plus xylazine. In ducks of the KET group, pHa, PaCO2, and PaO2, remained unchanged after administration of the drug. In ducks of the XYL group, pHa and PaO2 decreased significantly (P less than or equal to 0.05) from control values for all time points up to and including 15 minutes after drug administration.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of ketamine on electroencephalographic and autonomic arousal and segmental reflex responses in the cat

Objective To provide evidence concerning doses of ketamine that affect electroencephalographic (EEG) and autonomic signs of arousal during nociceptive stimulation. Study design Prospective psychophysical test in people. Single injection or progressively increasing infusions of ketamine in cats. Animals and people Seven people (20–60 years old) and three cats (3–5 kg) for EEG recording and six cats for EMG recordings. Methods In order to define innocuous and nociceptive stimulus intensities which could be applied to cats to evaluate arousal, psychophysical evaluations of sensations elicited by compression of the skin overlying phalangeal bones of the hand were obtained from human subjects. Then, following administration of ketamine, recordings of EEG frequency and of autonomic responses (heart rate, respiratory rate and arterial blood pressure) were obtained before and during stimulation of the tails of cats at pressures identified by human observers as either innocuous or nociceptive. Observations of withdrawal reflexes of the hindlimbs following interdigital skin stimulation were interposed between recording periods. In separate sessions, stretch reflex activity was assessed during awake and anesthetic conditions by recording electromyographic activity from soleus muscles and resistive force to dorsiflexion of the tibiotarsal joint. Results There were no changes in either total EEG (0.5–30.0 Hz), low‐frequency (0.6–7.5 Hz) or high‐frequency (7.5–30.0 Hz) power produced by nociceptive stimulation for a period of 18–24 minutes following an intramuscular bolus dose of ketamine (33.0 mg kg^?1), although withdrawal reflexes were present. Thereafter, nociceptive stimulation produced EEG arousal responses in the low‐frequency and total power range and increased systolic blood pressure and respiration rate. In tests after intravenous infusion of ketamine (10.0–22.2 mg kg^?1 hour^?1), total and low‐frequency EEG power and autonomic responses to nociceptive stimulation were eliminated. Organized motor responses were never elicited during IV infusion, but withdrawal reflexes were observed at each dosage. Also, stretch reflexes were shown by quantitative analysis to be retained at all doses of ketamine infusion. Conclusions and clinical relevance These results show that testing of withdrawal reflexes does not reveal the adequacy of ketamine anesthesia. Segmental stretch and withdrawal reflexes are preserved and can be investigated during infusion of ketamine at doses that eliminate arousal from brief periods of nociceptive stimulation.     

Effects of analog filtering on brain stem auditory-evoked potentials in dogs.

Effects of analog filter frequency on brain stem auditory-evoked potentials (BAEP) were investigated in 7 non-sedated dogs. The BAEP were recorded successively at various low-pass (LP) and high-pass (HP) filter frequency settings. The analog filters had a rolloff of 6 dB/octave. Decrease of LP filter frequency from 30 kHz to 100 Hz caused prolongation of the peak latency and reduction of the peak-to-peak (from a positive peak to the following trough) and absolute (from a positive peak to the baseline) amplitudes for all peaks, except the peak latency for P5 and the absolute amplitude for P4. Changes in these variables were statistically significant (P less than 0.05) at different cutoff frequencies specific for the individual peaks. The interpeak latency between P1 and P4, and P4/P1 peak-to-peak amplitude ratio were not changed significantly. At the lowest LP filter frequency of 100 Hz, positive peaks (fast waves) seemed to be superimposed on a slow positive wave (slow wave). In contrast, increase of HP filter frequency from 0.53 to 160 Hz did not result in significant changes for any peaks, except for reduction in the absolute amplitude of P4. The various effects of LP filter frequency and negligible effects of HP filter frequency on individual peaks may be attributable to their frequency composition and/or elimination of the slow wave at higher HP filter frequency settings. On the basis of our results, LP filter setting of 3 kHz and HP filter setting of less than or equal to 53 Hz are recommended for recording of BAEP in dogs.(ABSTRACT TRUNCATED AT 250 WORDS)     

Brain stem auditory-evoked response of the nonanesthetized dog

The brain stem auditory evoked-response was measured from a group of 24 healthy dogs under conditions suitable for clinical diagnostic use. The waveforms were identified, and analysis of amplitude ratios, latencies, and interpeak latencies were done. The group was subdivided into subgroups based on tranquilization, nontranquilization, sex, and weight. Differences were not observed among any of these subgroups. All dogs responded to the click stimulus from 30 dB to 90 dB, but only 62.5% of the dogs responded at 5 dB. The total number of peaks averaged 1.6 at 5 dB, increased linearly to 6.5 at 50 dB, and remained at 6.5 to 90 dB. Frequency of recognizability of each wave was tabulated for each stimulus intensity tested; recognizability increased with increased stimulus intensity. Amplitudes of waves increased with increasing stimulus intensity, but were highly variable. The 4th wave had the greatest amplitude at the lower stimulus intensities, and the 1st wave had the greatest amplitude at the higher stimulus intensities. Amplitude ratio of the 1st to 5th wave was greater than 1 at less than or equal to 50 dB stimulus intensity, and was 1 for stimulus intensities greater than 50 dB. Interpeak latencies did not change relative to stimulus intensities. Peak latencies of each wave averaged at 5-dB hearing level for the 1st to 6th waves were 2.03, 2.72, 3.23, 4.14, 4.41, and 6.05 ms, respectively; latencies of these 6 waves at 90 dB were 0.92, 1.79, 2.46, 3.03, 3.47, and 4.86 ms, respectively. Latency decreased between 0.009 to 0.014 ms/dB for the waves.     

Brain stem auditory-evoked response in the nonanesthetized horse and pony

The brain stem auditory-evoked response (BAER) was measured in 10 horses and 7 ponies under conditions suitable for clinical diagnostic testing. Latencies of 5 vertex-positive peaks and interpeak latency and amplitude ratio on the 1st and 4th peaks were determined. Data from horses and ponies were analyzed separately and were compared. The stimulus was a click (n = 3,000) ranging from 10- to 90-dB hearing level (HL). Neither horses nor ponies responded with a BAER at 10 dB nor did they give reliable responses at less than 50 dB. The 2nd of the BAER waves appeared in the record at lower stimulus intensities than did the 1st wave for the horse and pony. Horses and ponies had a decreasing latency for all waves, as a result of increasing stimulus intensity. Latencies were shorter for the ponies than for the horses at all stimulus intensities for the 1st, 2nd, 3rd, and 4th waves, but not the 5th wave. At 60-dB HL, the mean latencies for the 1st through 5th wave, respectively, for the horse were 1.73, 3.08, 3.93, 4.98, and 6.00 ms and for the pony 1.48, 2.73, 3.50, 4.56, and 6.58 ms. Interpeak latencies, 1st to 4th wave, averaged 3.22 ms (horse) and 3.11 ms (pony) for all stimulus intensities from 50- to 90-dB HL and had a tendency to decrease slightly as stimulus intensity increased. Amplitude ratios (4th wave/1st wave) were less than 1 for all stimulus intensities in the horse. In the pony, the ratio was less than 1 at greater than or equal to 70-dB HL and greater than 1 at less than or equal to 60-dB HL.     

Postnatal development of the brain stem auditory-evoked potential in dogs

Recordings of averaged brain stem auditory-evoked potentials were obtained from 13 Beagle pups of both genders to document the postnatal development of the response from age 1 to 76 days. Responses were recorded between needle electrodes placed on the vertex and the ipsilateral ear, with ground at the interorbital line. Recordings were performed without sedation. Low-amplitude responses to high-intensity stimuli could be recorded from animals prior to opening of the ear canals. Peak latencies did not change after day 20 for peak I, day 30 for peaks II and III, and day 40 for peak V. As a result, the interpeak latencies between peaks I and III did not change after day 30, but continued to decrease until day 40 for peaks III-V and I-V. Peak amplitudes reached plateau values by day 20 (peak I) or day 30 (peaks II, III, and V). All of the measured latency and amplitude values had significant (P less than 0.001) linear regression lines of latency vs age and amplitude vs age. The brain stem auditory-evoked potential thresholds were mature by day 20.     

Use of brain stem auditory-evoked response to evaluate deafness in a group of Dalmatian dogs

A group of 18 adult and 28 six-week-old purebred Dalmatian dogs was tested for hearing by brain stem auditory-evoked responses. Each ear was tested independently. Absence of a response was considered evidence of deafness in that ear. Responses from bilaterally hearing adults and pups and unilaterally hearing dogs were compared with each other and with responses from normally hearing, adult, mixed-breed dogs. Of the 18 adults tested, 5 had normal responses from both ears, 6 were deaf in both ears, and 7 had a response from only one side. Of 28 pups tested, 14 had normal responses from both ears, 9 had a response from only one ear, and 5 were bilaterally deaf. Wave peak latencies from all ears that responded were within normal limits, except that the 5th and 6th waves from unilaterally hearing adults had significantly longer latencies. There were no differences between males and females.     

Effects of xylazine/ketamine on cardiac function and serum ionised calcium in horses

Haemodynamic variables, with emphasis on right ventricular (RV) contractility, were measured in horses prior to, during and following anaesthesia with xylazine/ketamine. In an attempt to elicit mechanisms of anaesthetic-induced alteration of myocardial function, serum ionised and total calcium concentrations were also measured. Xylazine caused decreased cardiac function, including RV contractility, that was not reversed immediately by ketamine but was insignificant from pre-anaesthetic baseline by recovery (45 min following induction). Serum ionised and total calcium concentrations did not change.     

Effect of xylazine and ketamine on intraocular pressure in horses

Intraocular pressure was measured with a MacKay-Marg tonometer in eight horses following auriculopalpebral nerve block and topical application of lignocaine. Measurements were recorded before and after xylazine, 1.1 mg/kg intravenously, every two minutes for 16 minutes after administration of ketamine, 2.2 mg/kg intravenously, and after recovery from anaesthesia. Before xylazine, intraocular pressure was 17.1 +/- 3.9 and 18.4 +/- 2.2 mm Hg in the left and right eyes, respectively. Intraocular pressure tended to decrease after administration of xylazine and ketamine, with a significant decrease in one eye six minutes after injection of ketamine.     

Brain stem auditory-evoked responses in the dog

Brain stem auditory-evoked responses (BAER) were recorded from 58 dogs that did not have a known history of hearing problems. The BAER wave forms had an overall mean amplitude approximately 3.0 microV and typically consisted of a series of 4 to 5 vertex-positive peaks (peaks I through V). When acoustic clicks having intensities of 60-dB hearing level (decibels relative to the subjective hearing threshold) were used as stimuli, peak I had a latency of 1.49 +/- 0.13 ms; peak II, 2.32 +/- 0.14 ms; peak III, 3.01 +/- 0.25 ms; peak IV, 4.22 +/- 0.27 ms; and peak V, 5.55 +/- 0.37 ms. Latency values were influenced by a number of nonpathologic factors, including stimulus intensity and the body temperature of the dog. As stimulus intensity was decreased, there was a lengthening of the latency of each peak coupled with a decrease in the overall amplitude of BAER. Decreases in rectal temperature caused a similar lengthening of peak latencies. Age may have an influence on BAER, but under the conditions of the present study, the effect was not significant.     

Effects of ketamine on carfentanil and xylazine immobilization of white-tailed deer (Odocoileus virginianus).

Using a crossover design, the effects of the addition of ketamine to a previously determined optimal hand-injected immobilization dosage of carfentanil/xylazine were evaluated in 11 adult white-tailed deer (Odocoileus virginianus). Two i.m. ketamine dosages were evaluated: 0.15 mg/kg (low ketamine) and 0.30 mg/kg (high ketamine). Each deer was immobilized twice 2 wk apart. Inductions were video recorded and reviewed by observers, who had been blinded to drugs and dosages, who rated qualitative aspects. There were significant (P < 0.05) dosage-dependent decreases in heart rate, SaO2, and arterial pH, and a significant dosage-dependent increase in PaCO2. Induction times with both dosages were more rapid (mean 2.3 +/- 0.9 min for low ketamine and 2.3 +/- 0.6 min for high ketamine) than those reported for the same carfentanil/xylazine dosage used without ketamine. Mean quality ratings, though improved compared to those reported for carfentanil/xylazine alone, were considered "undesirable" for both dosages. Hyperthermia (temperature > 41 degrees C) was noted in 13 of 22 immobilizations. Arterial pH and PaO2 increased significantly from 10 to 20 min postrecumbency, but acidemia (pH < 7.3) was present throughout immobilization periods for all deer. There were ketamine dosage-dependent increases in respiratory components of this acidemia compared with that associated with carfentanil/xylazine alone. Possible hypoxemia was present at both sampling times for both groups, while hypercapnea (PaCO2 > 60 mm Hg) was present for the high-ketamine group only. Reversal times for naltrexone and yohimbine were rapid (mean 2.9 +/- 0.7 min for low ketamine and 3.3 +/- 0.8 min for high ketamine), with no evidence of renarcotization. Although the addition of ketamine to carfentanil/xylazine caused faster inductions and improved induction qualities, it also produced an increased incidence of hyperthermia, acidemia, hypoxemia, and hypercapnea. Supplemental oxygen and close monitoring of body temperature is recommended when using this immobilization regimen.     

Cardiopulmonary effects of a xylazine and ketamine combination in pigs

The carotid and pulmonary arteries were catheterised in six pigs anaesthetised with thiopentone sodium and halothane. A minimum of five days was allowed to elapse before the investigation. The carotid artery pressure, pulmonary artery pressure, cardiac output, arterial pH, PO2, PCO2, plasma glucose and lactate were measured before and after intravenous injection of xylazine (1 mg kg-1) and ketamine 10 mg kg-1). Complete analgesia was produced for 10 minutes in all pigs but by 25 minutes all animals responded to a painful stimulus. The cardiac output and arterial PO2 were significantly decreased for 30 minutes and 10 minutes, respectively. The total vascular resistance was significantly increased. No statistically significant changes occurred in the other variables measured.     

A comparative study of medetomidine/ketamine and xylazine/ketamine anaesthesia in dogs

The anaesthetic and physiological effects of a combination of 40 micrograms medetomidine with 2.5 ketamine, 5.0 or 7.5 mg/kg administered intramuscularly were compared with the effects of a combination of 1 mg/kg xylazine and 15 mg/kg ketamine. All the combinations rapidly induced an anaesthetic state that permitted endotracheal intubation, with the absence of the pedal reflex and with good muscle relaxation, and induced bradycardia that was less pronounced as the dose of ketamine was increased. All the combinations produced a decrease in respiratory rate. Increasing the dose of ketamine combined with medetomidine resulted in a very significant prolongation of the duration of anaesthesia, the duration of muscle relaxation and the arousal time. The duration of the anaesthetic effects of 40 micrograms/kg medetomidine with 5 mg/kg ketamine was comparable to that provided by the recommended xylazine/ketamine combination but the period of muscle relaxation was significantly longer. The recovery from medetomidine/ketamine took longer than recovery from xylazine/ketamine but there were fewer side effects.     

Correlation of brain stem auditory-evoked responses with cranium size and body weight of dogs

Brain stem auditory-evoked responses were recorded in 9 male and 11 female clinically normal mature dogs, weighing between 2 and 36 kg. Mean wave latency for the entire group of dogs, using 60-dB hearing level click stimuli at 11/s for waves I to VII was: 1.41, 2.21, 2.85, 3.31, 3.71, 5.12, and 6.46 ms, respectively. The mean interpeak latency for waves I and V (IPLIV) was 2.32 ms. Neither gender nor ear effect was detectable. Positive correlation was observed between cranium length, cranium width, nasion-external auditory meatus interval, and body weight for wave-V latency and IPLIV. Such correlation was not documented for wave I. The regression equations for their effects on IPLIV were: cranium length, y = 0.05x + 1.85; cranium width, y = 0.07x + 1.32; nasion-external auditory meatus interval, y = 0.05x + 1.79; and body weight, y = 0.01x + 2.15. On the basis of any of the 3 variables of cranium size or body weight, the study population could be classified into groups of large and small dogs, with the large group having significantly (P less than 0.05) longer latency for wave V and IPLIV. It is recommended that the effect of size variation in dogs on brain stem auditory-evoked responses should be compensated for by use of the regression equation based on cranium length.     

Effects of xylazine on the stress response to transport in male goats.

A 20-min van journey increased plasma cortisol concentrations to 15-25 ng/ml in male goats, blood glucose concentrations were not affected, but respiratory rates and heart rates were increased, the latter by 40 beats per min. A 2-h van journey increased plasma cortisol to greater than 25 ng/ml and blood glucose to greater than 5 mmol/l. Respiratory rates were increased to greater than 40 breaths per min and heart rates by greater than 100 beats per min. Xylazine alone (0.01 mg/kg) suppressed resting plasma cortisol concentrations, increased blood glucose concentrations to 4.5 +/- 0.8 mmol/l and suppressed respiratory rates by 5-10 breaths per min and heart rates by 20 beats per min. Cortisol concentrations were suppressed by xylazine treatment if given before a 20-min van journey, and for approximately 60 min if given 20 min after the start of a 2-h journey. When combined with transport, xylazine caused an additive effect on glucose concentrations, but suppressed respiratory and heart rates. However, for the latter criteria the timing of suppression was different depending on the time of onset and duration of the stressor. Injection of 50 micrograms ovine corticotrophin releasing factor (CRF) caused an immediate elevation of cortisol concentrations (but not glucose) which lasted for at least 6 h compared with the return to baseline within 60 min after either length of journey. Xylazine pretreatment did not alter the cortisol response to CRF, suggesting that xylazine must act centrally above pituitary level when blocking the cortisol response to transport. It is proposed that under resting conditions the hypothalamus is under alpha 2-adrenergic suppression. Stimulation of cortisol secretion in response to a stressor can be inhibited by an alpha 2-adrenergic agonist.     

Influence of the mode of ventilation on ketamine/xylazine requirements in rabbits

OBJECTIVE: To evaluate the effect of the mode of mechanical ventilation (MV) on the dose of intravenous anesthetic during 3 hours of ketamine/xylazine anesthesia. STUDY DESIGN: Prospective laboratory study. ANIMALS: Sixty-one adult male New Zealand White rabbits. METHODS: Rabbits were anesthetized (ketamine/xylazine 35 + 5 mg kg(-1), IM), the trachea was intubated and randomized to four groups - (1) CMV-1 (n = 14), ventilated with traditional conventional volume-cycled MV [V(T) = 12 mL kg(-1), RR = 20, positive end-expiratory pressure (PEEP) = 0 cmH(2)O]; (2) CMV-2 (n = 13), ventilated with a modern lung-protective regimen of volume-cycled MV (V(T) = 6 mL kg(-1), RR = 40, PEEP = 5 cmH(2)O); (3) HFPV (n = 17) ventilated with high-frequency percussive ventilation [high-frequency oscillations (450 minute(-1)) superimposed on 40 minute(-1) low-frequency respiratory cycles, I:E ratio = 1:1], oscillatory continuous positive airway pressure (CPAP) of 7-10 cmH(2)O, and demand CPAP of 8-10 cmH(2)O. (4) A fourth group, spontaneously ventilating (SV, n = 17), was anesthetized, intubated, but not ventilated mechanically. FiO(2) in all groups was 0.5. Anesthesia was maintained at a surgical plane by IV administration of a ketamine/xylazine mixture (10 + 2 mg kg(-1), as necessary) for 3 hours after intubation. Total dose of xylazine/ketamine administered and the need for yohimbine to facilitate recovery were quantitated. RESULTS: The total dose of xylazine/ketamine was significantly higher in the HFPV and SV groups compared with CMV-1 (p < 0.01). Fewer animals required yohimbine to reverse anesthesia in the HFPV than CMV-1 group (p < 0.05). CONCLUSIONS: The HFPV mode of MV led to higher doses of ketamine/xylazine being used than the other modes of MV. CLINICAL RELEVANCE: In rabbits, anesthetic dose for the maintenance of anesthesia varied with the mode of MV used. Investigators should be aware of the possibility that changing the mode of ventilation may lead to an alteration in the amount of drug required to maintain anesthesia.     

Evaluation of xylazine and ketamine for total intravenous anesthesia in horses

OBJECTIVE: To evaluate the use of xylazine and ketamine for total i.v. anesthesia in horses. ANIMALS: 8 horses. PROCEDURE: Anesthetic induction was performed on 4 occasions in each horse with xylazine (0.75 mg/kg, i.v.), guaifenesin (75 mg/kg, i.v.), and ketamine (2 mg/kg, i.v.). Intravenous infusions of xylazine and ketamine were then started by use of 1 of 6 treatments as follows for which 35, 90, 120, and 150 represent infusion dosages (microg/kg/min) and X and K represent xylazine and ketamine, respectively: X35 + K90 with 100% inspired oxygen (O2), X35 + K120-(O2), X35 + K150-(O2), X70 + K90-(O2), K150-(O2), and X35 + K120 with a 21% fraction of inspired oxygen (ie, air). Cardiopulmonary measurements were performed. Response to a noxious electrical stimulus was observed at 20, 40, and 60 minutes after induction. Times to achieve sternal recumbency and standing were recorded. Quality of sedation, induction, and recovery to sternal recumbency and standing were subjectively evaluated. RESULTS: Heart rate and cardiac index were higher and total peripheral resistance lower in K150-(O2) and X35 + K120-air groups. The mean arterial pressure was highest in the X35 + K120-air group and lowest in the K150-(O2) group (125 +/- 6 vs 85 +/- 8 at 20 minutes, respectively). Mean Pa(O2) was lowest in the X35 + K120-air group. Times to sternal recumbency and standing were shortest for horses receiving K150-(O2) (23 +/- 6 minutes and 33 +/- 8 minutes, respectively) and longest for those receiving X70 + K90-(O2) (58 +/- 28 minutes and 69 +/- 27 minutes, respectively). CONCLUSIONS AND CLINICAL RELEVANCE: Infusions of xylazine and ketamine may be used with oxygen supplementation to maintain 60 minutes of anesthesia in healthy adult horses.